Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease

Inclusion Criteria:

- Signs and symptoms of dry eye disease

- Has used RESTASIS and/or artificial tears in both eyes twice a day for at least 60
days.

Exclusion Criteria:

- History of glaucoma, or ocular hypertension

- Diagnosis of ocular infection

- Use of contact lenses in the past 14 days or expected use during the study

- Use of any topical ophthalmic medications in the past 30 days

- Use of corticosteroids in the past 30 days.